Three weeks ago, Dr
Ozempic is approved for blood sugar control and may help lower your risk of complications from heart disease, such as heart attack or stroke
Its promising, and in 10 years we might say, Hey, this stuff is great, what youre giving is pure and safe. But right now, its just so unregulated that we just dont know what these things really do in the human body, Spittler said
Continuing obesity therapy was tied to more than four times higher odds of 10% or greater weight loss
When you have both genetic insights and inflammatory biomarker context, you and your provider can have a more targeted conversation about whether compounded GLP-1 optionsincluding semaglutide injection ($189/mo), oral semaglutide ($289/mo+), tirzepatide injection ($289/mo), or oral tirzepatide ($349/mo)align with your health goals and expected anti-inflammatory benefits

Safety monitoring for GLP-1 therapy itself includes: Assessment for gastrointestinal adverse effects, which are common but usually transient Monitoring for signs of pancreatitis (severe, persistent abdominal pain) Vigilance for symptoms suggesting thyroid masses (neck lump, difficulty swallowing, persistent hoarseness) Regular review of glycaemic control in diabetic patients Blood pressure and cardiovascular risk factor assessment Monitoring for gallbladder disease (right upper abdominal pain, fever, jaundice) Eye examinations for people with diabetes, particularly those with pre-existing diabetic retinopathy Renal function checks, especially if experiencing severe gastrointestinal symptoms that could lead to dehydration If you have diabetes and take insulin or sulfonylureas, your doctor may reduce these doses when starting GLP-1 therapy to prevent hypoglycaemia